• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INSULET CORPORATION OMNIPOD 5 PDM CONTROLLER; INTEROPERABLE AUTOMATED GLYCEMIC CONTROLLER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INSULET CORPORATION OMNIPOD 5 PDM CONTROLLER; INTEROPERABLE AUTOMATED GLYCEMIC CONTROLLER Back to Search Results
Device Problem Defective Device (2588)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/27/2023
Event Type  Injury  
Event Description
Omnipod 5 controller software failure rendering pump uncontrollable.Second controller failure in three months.Reference reports: mw5115395 and mw5115396.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OMNIPOD 5 PDM CONTROLLER
Type of Device
INTEROPERABLE AUTOMATED GLYCEMIC CONTROLLER
Manufacturer (Section D)
INSULET CORPORATION
MDR Report Key16477744
MDR Text Key310732135
Report NumberMW5115397
Device Sequence Number1
Product Code QJI
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Unknown
Type of Report Initial
Report Date 02/28/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/02/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Was Device Available for Evaluation? Yes
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention;
Patient Age9 YR
Patient SexFemale
Patient Weight34 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-